Join fellow HCM alumni in raising funds for the the Castleman Disease Collaborative Network (CDCN)! Dedicated members of the class of 2015 and 2016 have formed fundraising committees in various cities (see below). Each committee is planning an event for 2016, and we are looking for more volunteers who can help spread the word. More information to come as events are finalized.
More information about David Fajenbaum and CDCN:
David Fajgenbaum, MD, MBA, MSc is a Research Assistant Professor of Medicine in the Division of Hematology/Oncology at the University of Pennsylvania and the co-founder and Executive Director of the Castleman Disease Collaborative Network (CDCN), a global network accelerating research and treatment discovery for Castleman disease (CD). Dr. Fajgenbaum’s research published in Blood caused a paradigm shift in how CD is researched and treated. Under Fajgenbaum’s leadership, the CDCN has facilitated global collaboration among its network of 300+ physicians and researchers; invested in five high-impact research projects; forged partnerships across industry, academia, and advocacy; and engaged the community of over 3,000 patients and loved ones throughout every step of the entire process.
For his work, Dr. Fajgenbaum was recently named a member of Forbes Magazine’s “30 Under 30” list for Healthcare and the 2015 “RARE Champion of Hope - Science” award winner. He received an MBA from The Wharton School, an MD from the Perelman School of Medicine at the University of Pennsylvania, a Masters in Public Health from the University of Oxford, and a BS from Georgetown University.
Please feel free to reach out to Emily Reid or Alex Burtoft if you’d like to be connected to an existing committee or would like to start one for a city not listed below.
Contact Emily and Alex:
Emily Reid at [email protected]
Alex Burtoft at [email protected]